CHU de Montpellier

Running trials

• Not yet recruiting

  Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy

  NCT07814001· Phase 2· Source

• Not yet recruiting

  Fasten Onco Digital Therapy During Neoadjuvant Treatment for Triple-Negative Breast Cancer

  NCT07884721· Source

• Recruiting

  French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls

  NCT07881016· Source

• Recruiting

  Continuous Monitoring of Plantar Temperature Variations Using Connected Insoles and a Mobile Application for Diabetic Foot.

  NCT07910721· Source

• Recruiting

  The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France

  NCT07211126· Source

• Recruiting

  Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis

  NCT07122089· Phase 2· Source

• Recruiting

  Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease

  NCT07257289· Source

• Recruiting

  Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin

  NCT06972901· Source

• Recruiting

  Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia

  NCT07099443· Source

• Not yet recruiting

  Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

  NCT06798532· Source

• Recruiting

  Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

  NCT07031817· Source

• Recruiting

  A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis

  NCT06865417· Phase 3· Source

• Not yet recruiting

  Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial

  NCT06263816· Phase 3· Source

• Recruiting

  Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma

  NCT06558604· Phase 2· Source

• Recruiting

  Patients with Coronary Artery Disease or At High Cardiovascular Risk: Measuring Compliance with Treatment for Obstructive Sleep Apnea Syndrome

  NCT06568159· Source

• Recruiting

  Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein

  NCT06441123· Source

• Recruiting

  Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease

  NCT05649514· Source

• Recruiting

  Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management

  NCT06627595· Source

• Recruiting

  Epidemiological Data on Mast Cell Pathologies in France

  NCT06186856· Source

• Active, not recruiting

  Screening for Chronic Liver Diseases in General Population

  NCT06366425· Source

• Recruiting

  Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach

  NCT06915649· Source

• Recruiting

  Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers

  NCT06425133· Phase 2· Source

• Recruiting

  Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

  NCT06271057· Phase 2· Source

• Recruiting

  French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)

  NCT06287723· Source

• Recruiting

  French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

  NCT06287814· Source

• Recruiting

  French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

  NCT06287749· Source

• Recruiting

  Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis

  NCT06083584· Source

• Recruiting

  Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.

  NCT06022016· Source

• Recruiting

  Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

  NCT05566769· Source

• Not yet recruiting

  Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity.

  NCT05946486· Phase 3· Source

• Recruiting

  Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination

  NCT05945524· Source

• Recruiting

  Forced Oscillations Technique During a Metacholine Test in Children

  NCT05734261· Source

• Recruiting

  Impact of an Early Identification Program for First-Episode Psychosis on the Duration of Untreated Psychosis

  NCT05813457· Source

• Recruiting

  Rheopheresis as Adjuvant Treatment of Calciphylaxis

  NCT04654000· Source

• Recruiting

  Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors

  NCT05649683· Source

• Recruiting

  Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

  NCT05528952· Phase 2· Source

• Recruiting

  AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

  NCT05198960· Phase 3· Source

• Active, not recruiting

  Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma

  NCT05208086· Source

• Recruiting

  Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

  NCT05246345· Source

• Active, not recruiting

  Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

  NCT04802590· Phase 2· Source

• Recruiting

  Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor

  NCT05937815· Source

• Recruiting

  Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura

  NCT04063540· Phase 2· Source

• Active, not recruiting

  Monitoring to the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®

  NCT04159987· Source

• Recruiting

  French Colorectal ESD Cohort in Experts Centers

  NCT04592003· Source

• Active, not recruiting

  Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)

  NCT04602091· Source

• Active, not recruiting

  Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

  NCT03981003· Source

• Active, not recruiting

  OFSEP High Definition Cohort

  NCT03603457· Source

• Recruiting

  Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

  NCT02828202· Source

• Recruiting

  UroCCR Database: French Research Network for Kidney Cancer -UroCCR

  NCT03293563· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer4 recruiting
• Melanoma3 recruiting
• Bipolar disorder2 recruiting
• Childhood cancers2 recruiting
• Chronic lymphocytic leukaemia2 recruiting
• Depression2 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Schizophrenia2 recruiting
• Type 1 diabetes2 recruiting
• Acute myeloid leukemia1 recruiting
• ALS (motor neurone disease)1 recruiting
• Alzheimer disease1 recruiting
• Asthma1 recruiting
• Autism1 recruiting
• Chronic kidney disease1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Cystic fibrosis1 recruiting
• Epilepsy1 recruiting
• Follicular lymphoma1 recruiting
• Heart failure1 recruiting
• High blood pressure1 recruiting
• HIV1 recruiting
• Kidney cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Mantle cell lymphoma1 recruiting
• Migraine1 recruiting
• Multiple myeloma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Neuroblastoma1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting
• Pancreatic cancer1 recruiting
• Triple-negative breast cancer1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  FERtility After Therapy With Intensive Lymphoma in Young Women: LNH-03 1B, LNH-03 2B, LNH-07 3B, GAINED Follow-up

  NCT06592846· Source

• Completed

  A Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic Fibrosis

  NCT06478706· Phase 2· Source

• Terminated

  Heart Failure Diagnostic Performance of an Expirogram Analysis Algorithm Evaluating 4 Biomarkers

  NCT06014593· Source

• Terminated

  Evaluation of the Efficacy of Two Guidance Techniques (Standard Injected CT vs Porto-scanner With Angio-CT) for Thermoablation Treatment of Colorectal Cancer Liver Metastases

  NCT05665322· Source

• Completed

  The Developmental Origins of Endometriosis

  NCT05951452· Source

• Completed

  Prognostic Impact of Guideline-recommended Timing for Invasive Strategy in NSTEMI

  NCT07204847· Source

• Completed

  Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis

  NCT05642208· Phase 4· Source

• Completed

  Extension Study Evaluating The Safety And Tolerability of AMX0035

  NCT05619783· Phase 3· Source

• Completed

  Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT

  NCT05524324· Source

• Completed

  Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia

  NCT05053932· Source

• Completed

  Effect of Increased Oxytocin Doses on the Mode of Delivery in Obese Primiparous Women With Spontaneous or Induced Labour

  NCT04760496· Phase 4· Source

• Completed

  Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)

  NCT04880434· Phase 2· Source

• Terminated

  Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy

  NCT04064697· Phase 3· Source

• Completed

  Mobile Technologies and Post-stroke Depression

  NCT04043052· Source

• Terminated

  Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease

  NCT04217447· Phase 3· Source

• Terminated

  Interest of the Dosage of Adalimumab Serum Levels in Crohn's Disease Patients for Prevention of Postoperative Recurrence

  NCT04200547· Source

• Terminated

  Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia

  NCT03765541· Phase 3· Source

• Completed

  Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits

  NCT04111211· Source

• Completed

  Simultaneous Portal and Hepatic Vein Versus Portal Vein Embolizations for Hypertrophy of the Future Liver Remnant

  NCT03841305· Phase 2· Source

• Terminated

  Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion

  NCT03727633· Phase 2· Source

• Completed

  Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C

  NCT02612129· Phase 2/3· Source

• Completed

  Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension

  NCT02579954· Source